Canadian researchers discover new BAX and/or BAK inhibitors for neurodegenerative disorders
Sep. 18, 2023
Researchers at Ontario Institute for Cancer Research and Sunnybrook Research Institute have described isoquinoline derivatives acting as apoptosis regulator BAX and/or BAK inhibitors reported to be useful for the treatment of neurodegenerative disorders.